Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Austria Belgium Denmark France Germany Italy +3
  • Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia Estonia France Germany Hungary Italy +3
  • Study of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain +1
  • Study on Anifrolumab for Adults with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria France Germany Hungary Italy +2
  • Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Spain
  • Study on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus

    Not recruiting

    1 1 1 1
    France Germany Spain
  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Croatia France Germany Greece Italy Portugal +1